LCAM
CELG

London & Capital Asset Management’s Celgene Corp CELG Stock Holding History

London & Capital Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,200
Closed -$218K – 99
2019
Q3 		$218K Hold
2,200
– – 0.04% 79
2019
Q2 		$203K Hold
2,200
– – 0.04% 88
2019
Q1 		$208K Buy
+2,200
New +$192K 0.03% 86

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

London & Capital Asset Management's CELG Position: Q4 2019 in Review

London & Capital Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,200 shares — an estimated $218K sold.

London & Capital Asset Management first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $218K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • London & Capital Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • London & Capital Asset Management sold 2,200 Celgene Corp shares in Q4 2019, an estimated $218K.
  • London & Capital Asset Management first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • London & Capital Asset Management's Celgene Corp position peaked at $218K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on London & Capital Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.